Disease recurrence following liver transplantation.

Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg (2000) 2.91

Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg (1998) 1.90

Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation. Am J Surg Pathol (1995) 1.08

Role of hepatitis C virus in chronic liver disease occurring after orthotopic liver transplantation. Arch Dis Child (1995) 0.76

The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39

Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists. Lancet (1997) 7.59

Differences in diagnostic criteria for esophageal squamous cell carcinoma between Japanese and Western pathologists. Cancer (2000) 4.55

Differences in the diagnostic criteria used by Japanese and Western pathologists to diagnose colorectal carcinoma. Cancer (1998) 3.98

Surgical anatomy of the hepatic arteries in 1000 cases. Ann Surg (1994) 3.83

Bacteriologic and surgical determinants of survival in patients with mycotic aneurysms. J Vasc Surg (1984) 3.65

Amanita poisoning: treatment and the role of liver transplantation. Am J Med (1989) 3.20

Cryptosporidial enteritis in a patient with congenital hypogammaglobulinemia. Hum Pathol (1979) 3.04

Lymphomas of the gastrointestinal tract: a study of 117 cases presenting with gastrointestinal disease. Cancer (1978) 2.85

Esophageal morphology from Linxian, China. Squamous histologic findings in 754 patients. Cancer (1994) 2.45

Association of primary sclerosing cholangitis with HLA-DRw52a. N Engl J Med (1990) 2.40

Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in Linxian, China. Cancer (1998) 2.39

Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population. Gut (2005) 2.31

Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest (1999) 2.29

Perforation of the gallbladder: a frequently mismanaged condition. Am J Surg (1979) 2.26

The Cronkhite-Canada Syndrome. An analysis of clinical and pathologic features and therapy in 55 patients. Medicine (Baltimore) (1982) 2.15

Distribution of dysplasias and early invasive carcinoma in Barrett's esophagus. Hum Pathol (1992) 2.11

Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology (1988) 2.06

Treatment of necrotizing soft tissue infections. The need for a new approach. Am J Surg (1985) 1.97

Long-term survival after retransplantation of the liver. Ann Surg (1997) 1.91

Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation. Am J Gastroenterol (1997) 1.91

Is colonoscopy needed for the nonadvanced adenoma found on sigmoidoscopy? The Polyp Prevention Trial. Gastroenterology (1998) 1.78

Ischemia and reperfusion injury in liver transplantation. Transplant Proc (2005) 1.77

A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients. Ann Surg (2001) 1.73

Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation. Am J Transplant (2011) 1.71

Infections in liver transplant recipients. Clin Infect Dis (1995) 1.71

Squamous esophageal histology and subsequent risk of squamous cell carcinoma of the esophagus. A prospective follow-up study from Linxian, China. Cancer (1994) 1.68

Histopathologic changes seen in esophagectomy specimens from the high-risk region of Linxian, China: potential clues to an etiologic exposure? Hum Pathol (1998) 1.65

Lymphoid hyperplasia of the gastrointestinal tract. A study of 26 cases and review of the literature. Am J Surg Pathol (1978) 1.63

Correlation between donor age and the pattern of liver graft recovery after transplantation. Transplantation (1995) 1.63

Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1999) 1.63

The role of liver biopsy in evaluating acute allograft dysfunction following liver transplantation: a clinical histologic correlation of 34 liver transplants. Hum Pathol (1988) 1.60

Long-term results of pediatric liver transplantation: an analysis of 569 transplants. Ann Surg (1998) 1.59

Current treatment modalities for hepatocellular carcinoma. Ann Surg (1994) 1.59

Identification of tissue-invading bacteria in human periodontal disease. J Periodontal Res (1982) 1.54

Development and evaluation of the Liver Disease Quality of Life instrument in persons with advanced, chronic liver disease--the LDQOL 1.0. Am J Gastroenterol (2000) 1.53

Moxalactam therapy for bacterial infections. Arch Intern Med (1981) 1.53

Major challenges limiting liver transplantation in the United States. Am J Transplant (2011) 1.50

The diagnosis and management of visceral artery aneurysms. Surgery (1980) 1.49

Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology (1998) 1.48

Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg (1990) 1.45

Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections. Ann Surg (1990) 1.43

Heavy chain ferritin acts as an antiapoptotic gene that protects livers from ischemia reperfusion injury. FASEB J (2003) 1.42

Is the preferential use of polytetrafluoroethylene grafts for femoropopliteal bypass justified? J Vasc Surg (1988) 1.40

Randomized, double-blind trial of anidulafungin versus fluconazole for prophylaxis of invasive fungal infections in high-risk liver transplant recipients. Am J Transplant (2014) 1.40

Mycobacterial infections after pediatric liver transplantation: a report of three cases and review of the literature. J Pediatr Gastroenterol Nutr (1995) 1.39

Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature. Liver Transpl (2001) 1.35

Isolation of histamine-containing cells from rat gastric mucosa: biochemical and morphologic differences from mast cells. Gastroenterology (1981) 1.35

Liver transplantation today. Ann Intern Med (1986) 1.34

Aortic saddle embolus. A twenty-year experience. Ann Surg (1983) 1.30

Infectious complications in liver transplantation. Arch Surg (1988) 1.29

Heme oxygenase-1 overexpression protects rat livers from ischemia/reperfusion injury with extended cold preservation. Am J Transplant (2001) 1.29

Clinical and laboratory studies into the pathogenesis of malacoplakia. J Clin Pathol (1976) 1.27

Carotid artery stenosis - hemodynamic significance and clinical course. JAMA (1981) 1.25

Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients. Lancet (1995) 1.24

Biliary strictures complicating liver transplantation. Incidence, pathogenesis, management, and outcome. Ann Surg (1992) 1.23

Studies of esophageal balloon cytology in Linxian, China. Cancer Epidemiol Biomarkers Prev (1997) 1.23

Collagenous colitis: a study of the distribution of morphological abnormalities and their histological detection. Hum Pathol (1999) 1.22

Fulminant hepatic failure: the role of liver transplantation as primary therapy. Am J Surg (1987) 1.22

Predictors of survival after In vivo split liver transplantation: analysis of 110 consecutive patients. Ann Surg (2000) 1.21

Pathogenesis of aortoduodenal fistula: experimental and clinical correlates. Surgery (1979) 1.20

Imipenem therapy of Pseudomonas aeruginosa and other serious bacterial infections. Antimicrob Agents Chemother (1984) 1.20

Outcomes of colonization with MRSA and VRE among liver transplant candidates and recipients. Am J Transplant (2008) 1.20

An unusual cause of massive gastrointestinal hemorrhage. Carcinoid tumor of the ileum. JAMA (1978) 1.19

Natural history of nonstenotic, asymptomatic ulcerative lesions of the carotid artery. A further analysis. Arch Surg (1982) 1.18

Focal fatty change of the liver, a hitherto poorly recognized entity. Gastroenterology (1980) 1.18

Gastric epithelial dysplasia and adenoma: historical review and histological criteria for grading. Hum Pathol (1997) 1.17

The use of the supraceliac aorta for hepatic arterial revascularization in transplantation of the liver. Surg Gynecol Obstet (1991) 1.17

Successful orthotopic liver transplantation for lamivudine-associated YMDD mutant hepatitis B virus. Gastroenterology (2000) 1.17

Effect of prophylactic antibiotics in acute nonperforated appendicitis: a prospective, randomized, double-blind clinical study. Ann Surg (1981) 1.17

Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann Surg (1997) 1.16

The endocrine cells of the gastrointestinal tract. Tumors. Part II. Pathol Annu (1986) 1.14

In situ splitting of the cadaveric liver for transplantation. Transplantation (1997) 1.14

Liver transplantation in patients with portal vein thrombosis and central portacaval shunts. Ann Surg (1991) 1.13

Preoperative factors associated with outcome and their impact on resource use in 1148 consecutive primary liver transplants. Transplantation (2001) 1.13

Diffuse hepatocyte ballooning in liver biopsies from orthotopic liver transplant patients. Histopathology (1991) 1.13

Improved results of liver transplantation in patients with portal vein thrombosis. Arch Surg (1996) 1.12

Gastric morphology and serum gastrin levels in pernicious anaemia. Gut (1976) 1.12

Effect of a prior portasystemic shunt on subsequent liver transplantation. Ann Surg (1989) 1.12

Xanthogranulomatous cholecystitis: case report and review of the literature. Arch Pathol Lab Med (1982) 1.11

Orthotopic liver transplantation for hepatobiliary malignancy. Report of three cases of special interest. Transplantation (1986) 1.10

Acinar-endocrine cell tumor of the pancreas. Report of a pancreatic tumor containing both zymogen and neuroendocrine granules. Cancer (1982) 1.10

Collagenase activity of the human aorta. A comparison of patients with and without abdominal aortic aneurysms. Arch Surg (1980) 1.09

Splenectomy for hematologic disease. The UCLA experience with 306 patients. Ann Surg (1984) 1.08

Gastrointestinal lymphomas. Immunohistochemical studies on the cell of origin. Am J Surg Pathol (1985) 1.08

Demonstration of estrogen receptors by monoclonal antibody in formalin-fixed breast tumors. Lab Invest (1988) 1.06

Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients. Transplantation (1998) 1.05

An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy. Liver Transpl (2000) 1.05

Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the Dysplasia Trial in Linxian, China. Cancer Epidemiol Biomarkers Prev (1994) 1.05

FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial. Transplantation (1995) 1.05

Hepatic artery reconstruction during liver transplantation. Transplantation (1989) 1.05

Advances in pediatric liver and intestinal transplantation. Am J Surg (2000) 1.04

Squamous dysplasia and early esophageal cancer in the Linxian region of China: distinctive endoscopic lesions. Gastroenterology (1993) 1.04

Characterization of human xenoreactive antibodies in liver failure patients exposed to pig hepatocytes after bioartificial liver treatment: an ex vivo model of pig to human xenotransplantation. Transplantation (1999) 1.04

Variables influencing the outcome following orthotopic liver transplantation. Arch Surg (1987) 1.04

Bile duct varices. An alternative to portoportal anastomosis in liver transplantation. Transplantation (1986) 1.04

Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1. Ann Surg (1998) 1.03

The superiority of synthetic arterial grafts over autologous veins in carotid-subclavian bypass. J Vasc Surg (1986) 1.02